))
051: Ada Le and Mousumi Sannigrahi on behavioural science in healthcare
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on December 27, 2024 11:08 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 404797533 series 3556050
内容由Daniel Ross and Dan Biggar, Daniel Ross, and Dan Biggar提供。所有播客内容（包括剧集、图形和播客描述）均由 Daniel Ross and Dan Biggar, Daniel Ross, and Dan Biggar 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
This week we’re diving into healthcare; what could be more critical? To help me understand how behavioural science is impacting this field, I’m joined by Dr. Ada Le, healthcare expert at BEworks and Dr. Mousumi Sannigrahi, newly installed as Head of Commercial for Innovative Medicines at Fosun Pharma US, having spent the last 8 years at Novartis Pharma.
Show notes
- What’s happening at the intersection of behavioural science and the pharma industry?
- How behavioural science plays out at Fosun vs. Novartis
- The next frontier for healthcare and behavioural science
- What needs to happen to move to a more human-centric approach to healthcare?
- The goal of the 1% Steps for Health Care Reform Project
- What are easy wins that the pharma industry can enact now?
- Psychological barriers for patients with autoimmune disease
- Rosy retrospection bias and failure to prescribe the right treatment
- David Robson and expectation effects: how mindset can alter our lives
- Dan Ariely’s end of life theories and research
- The scientific method of problem solving vs. more subtle placebo effects
- Hopes for healthcare in the next year
Please leave a review if you like the podcast; and share with friends. Your support makes us very happy!
85集单集
分享
